Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Tsunezumi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Cellular Biochemistry|January 29, 2009
Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activityJun Tsunezumi, Shouichi Higashi, Kaoru Miyazaki
The FEBS Journal|August 30, 2008
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfacesJun Tsunezumi, Kazuhiro Yamamoto, Shouichi Higashi, et al.
The Journal of Biological Chemistry|February 16, 2006
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesionKazuhiro Yamamoto, Shouichi Higashi, Mitomu Kioi, et al.
Journal of Cellular Physiology|November 12, 2022
Fibulin7 aggravates calcium oxalate-induced acute kidney injury by binding to calcium oxalate crystalsHidekazu Sugiura, Jun Tsunezumi, Hiromi Yanagisawa, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2018
Nephronectin Regulates Mesangial Cell Adhesion and Behavior in GlomeruliSusan E Zimmerman, Chitkale Hiremath, Jun Tsunezumi, et al.
Oncology Reports|January 6, 2011
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikisYuji Sakuma, Jun Tsunezumi, Yoshiyasu Nakamura, et al.
Nature Communications|May 12, 2025
HR eye & MMR eye: one-day assessment of DNA repair-defective tumors eligible for targeted therapyShinta Saito, Shingo Kato, Usaki Arai, et al.
Biological & Pharmaceutical Bulletin|October 1, 2020
Effects of M-1, a Major Metabolite of Sarpogrelate, on 5-HT-Induced Constriction of Isolated Human Internal Thoracic ArteryNaoko Tanaka-Totoribe, Muneaki Hidaka, Shuji Gamoh, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Epithelial tubule interconnection driven by HGF-Met signaling in the kidneyIsabel López-García, Sunhee Oh, Chris Chaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2024
Epithelial tubule interconnection driven by HGF-Met signaling in the kidneyIsabel López-García, Sunhee Oh, Christopher Chaney, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|January 29, 2009
Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activityJun Tsunezumi, Shouichi Higashi, Kaoru Miyazaki
The FEBS Journal|August 30, 2008
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfacesJun Tsunezumi, Kazuhiro Yamamoto, Shouichi Higashi, et al.
The Journal of Biological Chemistry|February 16, 2006
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesionKazuhiro Yamamoto, Shouichi Higashi, Mitomu Kioi, et al.
Journal of Cellular Physiology|November 12, 2022
Fibulin7 aggravates calcium oxalate-induced acute kidney injury by binding to calcium oxalate crystalsHidekazu Sugiura, Jun Tsunezumi, Hiromi Yanagisawa, et al.
Journal of the American Society of Nephrology : JASN|January 17, 2018
Nephronectin Regulates Mesangial Cell Adhesion and Behavior in GlomeruliSusan E Zimmerman, Chitkale Hiremath, Jun Tsunezumi, et al.
Oncology Reports|January 6, 2011
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikisYuji Sakuma, Jun Tsunezumi, Yoshiyasu Nakamura, et al.
Nature Communications|May 12, 2025
HR eye & MMR eye: one-day assessment of DNA repair-defective tumors eligible for targeted therapyShinta Saito, Shingo Kato, Usaki Arai, et al.
Biological & Pharmaceutical Bulletin|October 1, 2020
Effects of M-1, a Major Metabolite of Sarpogrelate, on 5-HT-Induced Constriction of Isolated Human Internal Thoracic ArteryNaoko Tanaka-Totoribe, Muneaki Hidaka, Shuji Gamoh, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Epithelial tubule interconnection driven by HGF-Met signaling in the kidneyIsabel López-García, Sunhee Oh, Chris Chaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2024
Epithelial tubule interconnection driven by HGF-Met signaling in the kidneyIsabel López-García, Sunhee Oh, Christopher Chaney, et al.
Pageof 2